The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2024 | Deep learning algorithms for monitoring pancreatic cancer progression and risk assessment
Davide Placido, PhD, University of Copenhagen, Copenhagen, Denmark, discusses the development of a model for early detection of pancreatic cancer using disease trajectory from the Danish National Patient Registry. This model has the potential to improve screening criteria for pancreatic cancer as well as to provide personalized risk to patients. This interview took place at the 2024 ASCO Gastrointestinal (GI) Cancers Symposium in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
